Barclays cuts Evonik to “equal weight” as Q1 rally limits near-term upside

Investing.com Gold reports: Barclays cuts Evonik to “equal weight” as Q1 rally limits near-term upside. Full body text was unavailable at ingest time, so this brief is based on headline context.